Phase I trial of CYC 116 in patients with haematological malignancies.
Phase of Trial: Phase I
Latest Information Update: 08 Apr 2011
At a glance
- Drugs CYC 116 (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- Sponsors Cyclacel
- 08 Apr 2011 Status changed from planning to unconfirmed (development of this drug for this indication was never initiated).
- 25 Oct 2007 New trial record.